RNS
TARO

Robert N. Shapiro’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Robert N. Shapiro’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4K Buy
+26
New +$3.82K ﹤0.01% 787

Other funds holding TARO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
GCM
Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Robert N. Shapiro's TARO Position: Q4 2014 in Review

Robert N. Shapiro opened a new position in Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2014: 26 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #787 among its holdings.

89 funds tracked by Wall St. Rank hold TARO as of Q4 2014.

  • Robert N. Shapiro held 26 shares of Taro Pharmaceutical Industries Ltd. worth $4K as of Q4 2014.
  • Taro Pharmaceutical Industries Ltd. was a new Robert N. Shapiro position in Q4 2014.
  • Taro Pharmaceutical Industries Ltd. made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #787 holding.
  • 89 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.